Cancers, Vol. 12, Pages 921: The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation
Conclusions: Our data show that baseline GPS correlates with rates of relapse and refractory disease in MM patients undergoing autologous transplantation. In a multivariate analysis, these effects were proven to hold prognostic capabilities beyond and independent from established prognosticators. These results require further validation in a prospective setting.
Source: Cancers - Category: Cancer & Oncology Authors: Hanno M. Witte Bastian Bonorden Armin Riecke Harald Biersack Konrad Steinestel Hartmut Merz Alfred C. Feller Veronica Bernard Sebastian Fetscher Nikolas von Bubnoff Niklas Gebauer Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Myeloma | Pathology | Stem Cell Therapy | Stem Cells | Study | Transplants